Clinical Trial Update: Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating atorvastatin for lithium-induced nephrogenic diabetes insipidus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrogenic Diabetes Insipidus

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Lady Davis Institute | Conditions: Lithium Use, Nephrogenic Diabetes Insipidus | Phase 2 | Status: COMPLETED